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A computerized medication monitoring system for alerting 
and warning of potential adverse drug reactions is described. 
The system integrates computerized data on each hospital 
patient (medications, clinical laboratory, blood gas, ECG, aller-
gies, diagnosis, etc.) and returns to the pharmacist warning 
messages and suggestions regarding patient drug therapy. The 
broad data base allows for nearly complete drug therapy moni -
toring. When a warning message is received, the pharmacist 
contacts the physician or nursing staff and explains the poten-
tial problem. The system also generates prescription labels and 
patient drug profiles which are used in a unit dose dispensing 
system. 
Five percent of 13,727 patients monitored have had drug 
alerts. Of these alerts, 44.9% were drug-laboratory contraindica-
tions and only 28.9% were drug-drug interactions. Of the 690 
alerts received, 77% resulted in the physician changing the pa-
tient's therapy. 
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Adverse drug reactions are a recognized health care prob-
lem. It has been shown that as the number of drugs admin-
istered increases, the risk of adverse drug reactions increases 
rapidly. Cluff and associates1 reported that hospitalized 
patients receiving 0-5 drugs during their hospital stay ex-
perienced adverse drug reactions 4.2% of the time, while 
patients receiving 16-20 drugs experienced adverse drug 
reactions 40% of the time. Drug surveillance studies cur-
rently are being conducted to detect and evaluate adverse 
drug reactions, their clinical significance and factors which 
predispose a patient to a reaction. Jick and associates of the 
Boston Collaborative Drug Surveillance Program,2 Cluff and 
associates, 1•3•4 and the Kaiser-Permanente Foundation5 are 
some of the groups involved in this epidemiological study 
of drugs and their adverse effects. 
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The difficult role of prevention of adverse drug reactions 
is the responsibility of the physician, the pharmacist and the 
nurse. The physician often lacks time to obtain needed drug 
prescribing information. The pharmacist does not have 
convenient access to vital information in the patient chart 
that is required to monitor for proper drug therapy (i.e., 
diagnosis, laboratory data, weight, etc.). The nurse often 
lacks both adequate time and knowledge of drugs. As are-
sult, gathering of drug prescribing information and screening 
for drug contraindications often occur only after the patient 
already has received the drug. 
Computer programs have been developed to aid in the 
prevention of adverse drug interactions. Cohen at Stanford 
University Medical Center6 and Maronde and associates at 
the Los Angeles County-University of Southern California 
Medical Center7 have two of the best developed computer-
ized drug alert systems. These computer programs search 
for matches between drug pairs in the patient's profile via 
a drug-drug interaction matrix. When matches are found, 
"alert" reports are generated to notify the physician of a 
potential drug-drug interaction. Although it is known that 
drug monitoring includes more than drug-drug interactions, 
the lack of an adeq·uate patient data base has prevented 
these computer programs from evaluating other contrain-
dications. This paper describes a recently implemented 
pharmacy computer system which uses the patient's com-
plete medical record to provide alerts on potential adverse 
drl!-g reactions. By considering more of the patient's data, 
better and more complete drug monitoring can occur. This 
system monitors not only drug-drug interactions, but also 
drug allergies, drug laboratory interactions, drug-disease 
interactions, digitalis therapy, aminoglycoside therapy and 
anticoagulant therapy. 
Description of System 
The LDS Hospital in Salt Lake City, Utah, is a 550-bed 
hos~ital with a clinical computer system which gathers data 
from many areas to form a broad patient data base.s Data 
are gathered both automatically and manually through in-
teractive programs from many hospital data sources (Figure 
1). Most data are entered automatically or by paramedical 
personnel and therefore do not require physician effort. 
Patient histories are computerized and are self-adminis-
tered. 
The pharmacy uses a unit dose dispensing_ system with a 
24-hour supply. Drug orders are sent from the nursing di-
visions to the pharmacy where the pharmacist enters them 
via a terminal into the patient's computer file. To enter a 
drug order, the pharmacist first enters the patient's hospital 
number. The patient's name is displayed for verification. 
Next, the name of the drug or the drug's code number is 
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entered. Trade names, generic names or abbreviations may 
be entered. For example, one may enter the generic name 
(hydrochlorothiazide), a trade name (Esidrix, Hydrodiuril, 
etc.), an abbreyiation (HCT) or a drug code (130104). Re-
gardless of which of the above is entered, "Hydrochlorothi-
azide x mg" always is returned. Subsequently, the dose, route 
and schedule of administration are entered. Upon comple-
tion of entering the drug order, the prescription is redis-
played for con!rrmation. When a drug order is discontinued, 
the pharmacist enters this information thus keeping the 
patient's medication profile current. 
Drug allergies written in admitting orders are sent to the 
pharmacy where they are entered into the computer. The 
pharmacist may enter an allergy to a particular drug or to 
a class of drugs (e.g., tetanus toxoid, penicillins). 
A unique computer program allows the integration of the 
patient's computerized data for the purpose of making 
clinical decisions. The HELP (ljealth ~valuation through 
~ogical :Processing) computer system was developed to allow 
experts in a medical specialty to define the rules and criteria 
for medical decision making. Once established, the criteria 
set is applied to all patients. Alerts are generated when the 
previously defined criteria are met.9,lO 
Criteria for each decision are established by pharmacol-
ogists, pharmacists and physicians who review the literature 
and incorporate their clinical experience into a given decision 
(Figure 1). These criteria become unique segments of logic 
(HELP decision sector) having specific diagnostic messages 
associated with them. HELP sectors are stored on a magnetic 
disc and then automatically applied to all patients receiving 
drug therapy. Each HELP sector consists of a message, a 
final evaluation statement, and data and logic items (Figure 
2). When the sector is "true," the alert message is returned 
to the user. The final evaluation designates the items re-
quired for the sector to be true. Figure 2 shows some of the 
types of items that are possible. Item A defines a search for 
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Figure 2. "HELP" sector which alerts the physician when a patient is re· 
ceiuing an aminoglycoside and renal function is not being monitored (see 
tex t discussion) 
Message: Suggest that serum cteatinine is checked every three days 
when using gentamicin, kanamycin, streptomycin, or tobra-
mycin 
Final Evaluation: A and not B 
Items; 
A Anti-infectives , (A) aminoglycosides, (B) neomycin, (C) cur-
rent. Boolean statement: C and A and not B; order must be at 
least 10 hours old. 
B (A) creatinine clearance, (B) serum creatinine, (C) amino-
glycoside blood level. Boolean statement: A or B or C; must be 
in the last three days. 
the presence of a class of drugs (anti-infectives), a subclass 
(aminoglycosides), and excludes the specific aminoglycoside, 
neomycin. The Boolean logica statement associated with 
item A controls the data search by requiring that the patient 
is currently (C) receiving an aminoglycoside (A) that is "not" 
neomycin (B). Item A also specifies that the drug order be 
at least 10 hours old. An item may define a mathematical 
manipulation or a special pharmacokinetic function to de-
termine drug effects on the individual patient. Data from the 
entire patient data base may be used in forming logic. For 
example, item B of Figure 2 retrieves patient creatinine 
clearance, serum creatinine and aminoglycoside blood level 
data. 
The broad data base and the flexibility of the HELP 
system allow for complete drug monitoring. For example, 
concomitant administration of 6-mercaptopurine and allo-
purinol may result in 6-mercaptopurine toxicity unless the 
dose of 6-mercaptopurine is reduced.l 1 The HELP sector 
which monitors for this drug-drug interaction makes a dose 
calculation (mg/kg/day) to determine if the necessary dose 
reduction has occurred. A warning message is given only if 
the physician has not already made the necessary dose re-
duction. For the concomitant administration of tetracycline 
and antacids, 12 the sector checks to insure that the tetracy-
cline is being given orally and that the antacid also is 
scheduled. At the time a drug or an allergy is entered into the 
:Ratient's file, it is checked automatically by all the HELP 
sectors for alert conditions. When the criteria for an alert are 
met, a warning message is displayed on the computer ter-
minal and a hard copy of the message is printed. For exam-
ple, "allergy history suggests penicillins may be contrain-
dicated," would appear on the terminal if ampicillin were 
entered on a patient allergic to penicillins. If no contrain-
dication is found, the computer requests the scheduling of 
the next dtug order. 
Although the computer automatically monitors drug 
therapy, occasionally the pharmacist may still have a ques-
• Boolean logic involves logical true/false determinations by the specific 
references from an item list with logical operators (i.e., and , or, not, greater 
than, less than). 
tion about a drug order. The pharmacist may instruct the 
computer terminal to print information about a patient's 
laboratory data, admitting diagnosis, diet, decision list, 
weight, height, age, sex or room assignment. For example, 
the computer may give a warning message that the patient 
is receiving digitalis and has a low serum potassium con-
centration. In this case, the pharmacist may inquire from the 
system the previous potassium concentrations or the pa-
'tient's serum creatinine. 
Simultaneously, when confirmation of a drug order is 
given, it is stored in the patient's file and a prescription label 
is generated by a printer. Prescription labels are generated 
for all non-floor stock drug orders, and are used on medica-
tion that is sent to the floor before the next unit dose medi-
cation drawer exchange. 
A computer medication profile is kept for each patient. 
This profile allows the pharmacist to review, from a terminal, 
all drugs currently being given to the patient, all discontin-
ued drug orders, or drug allergies. A hard copy of the current 
medication profile may be generated on a line printer in the 
pharmacy (Figure 3). Medication profiles may be produced 
either for an individual patient or for a nursing division. 
Typically, a pharmacy technician will request profile 
printouts for a given nursing division to be used to fill the 
unit-dose medication carts. The pharmacist is responsible 
for followup on every drug alert. After receiving a warning 
message, he may review the patient chart and discuss the 
problem with the physician, leave the computer-generated 
warning message with a written note in the patient's chart 
for the physician, contact the appropriate medication nurse, 
or refer the warning message to another pharmacist for fol-
lowup. 
Figure 4 is an example of a HELP sector which monitors 
digitalis therapy. Item A requires that the patient be cur-
rently receiving digitalis therapy, item B is for potassium 
supplement, while item C specifies a search for the most 
recent serum potassium laboratory result. The final evalu-
ation statement defines the criteria for generating an alert 
for this sector. That is, if the patient is receiving digitalis 
(item A), is not receiving a potassium supplement (item B), 
and has a potassium l evel (item C) of less than 3.4 mEq/liter, 
the warning message is given suggesting that a potassium 
supplement be ordered. 
Evaluation 
There are 149 drug-monitoring HELP sectors in use. 
HELP sectors are continuously being added to enlarge or 
revise update areas of drug therapy monitoring. 
A ten-month experimental program was completed seven 
months ago, where all drugs ordered on two medical divisions 
and one surgical division (86 beds) were monitored. The 
system has since been expanded to include almost all hos-
pital patients. The results of the data collected in the first 
16 months of monitoring are shown in Table 1. A total of 
88,505 drug orders for 13,727 patients have been monitored. 
It was found that 690 (0.8%) drug orders resulted in a 
warning message on 5.0% of all patients. Physician accep-
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Figure 3. Example of a computer-generated patient medication profile used 
in the unit dose system (see text discussion) 
PATIENT MEEliCATION PROFILE 
14:43 6 / 11 / 76 
Test. Terry Pt. Number: 123456 
Dr. Warner, Homer R. 
Sensitivities: Penicillins 
Ht: 160 em WI: 80.0 kg 
1. Ampicillin 250 mg, oral. q.i.d. 
2. Col ace 100 mg. oral, q.d . 
3. Digoxin 0.250 mg. oral, q.d. 
4. * Meperidine 100.0 mg, i.m .• q. 4 h. prn. floor stock 
5. * Flurazepam 30 mg. oral, h.s. prn. floor stock 
Room: 441 
Age: 30 
Figure 4. "HELP" sector which alerts-physician to patients who are receivin!{ 
digitalis, are not receiving potassium and have a low serum potassium (s ee 
text discussion) 
Message: Suggest potassi~m supplement. as patient's low serum potas-
sium concentration may result in digitalis toxicity 





Digitalis (BI Current 
(A) Potassium supplement (B) Current 
(A) Serum potassium concentration last 
Table 1. Results of Computer Alerts, Their Causes and 
Actions Taken 
Sectors Warnings Therapy 
Changes 
Sector Type No. % No. % (%) 
Drug-drug 52 34.9 199 28 .9 79.9 
Drug-allergy 44 29.5 112 16.2 56.3 
Drug-laboratory 30 20.1 310 44.9 79 .7 
Drug-di sease 9 6.1 0 0 0 
Drug-dose 6 4.0 50 7.3 94.0 
Drug-diet 4 2.7 9 1.3 77 .8 
Drug-route 2 1.3 2 0 .3 100.0 
Drug-interval 1 0.7 3 0.4 66.7 
Alternate drug 0.7 5 0 .7 100.0 
Totals 149 100 690 100 77.1 
T ota l number of patients monitored : 13, 727 
Total number of drug warning messages: 690 (5.0%) 
' 
tance of the system has been enthusiastic. Five hundred 
thirty-two (77.1%) of the warning messages resulted in a 
change in therapy. Patient-reported allergies which the 
physician later believed not to be true allergies accounted 
for 48 (30%) of the warning messages that did not result in 
a change in tl).erapy. Compliance corrected for this "soft" 
allergy data is 82.9%. 
A comparison of types of HELP sectors and numbers of 
warning messages received is shown in Table 1. An important 
need to integrate laboratory data to monitor medication 
therapy is indicated by the fact that while HELP sectors 
involving both drug and laboratory data constitute only 
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20.1% of all medication HELP sectors, they are responsible 
for 44.9% of all warning messages received. 
The success of this program, in large measure, can be at-
tributed to the interface of the pharmacist with the computer 
system. The pharmacist uses the warnings produced by the 
computer to alert him to problems he should investigate. It 
is his responsibility to follow up on all warnings. He keeps 
a record of each alert, the effect of the alert on patient 
therapy and any 1dverse reactions that occur. This infor-
mation is subsequently used to determine needed changes 
and updates in the HELP sector logic and provides statistics 
on physician acceptance. The computer, therefore, does not 
directly interface with the physician nor is it dictating to the 
physician how to practice medicine. Instead, it serves as a 
means of education and of constant surveillance, commun-
icating with him through the pharmacist. 
Examples of Usefulness of System 
The following clinical cases will serve to illustrate the 
system's utility. 
Patient A.H . was started on gentamicin 80 mg i.v. every 
eight hours. Since neither a creatinine clearance, a serum 
creatinine, nor a gentamicin blood concentration was avail-
able on the patient, the computer advised that the serum cre-
atinine should be monitored . The test was ordered by the 
physician giving a result (serum creatinine 10.6 mg/ 100 ml) 
indicating severe renal failure. Therapy was altered because 
of this information. Toxic concentrations of gentamicin 
would have been reached had the warning message not been 
given. 
Patient M.H. was admitted with a diagnosis of severe con-
gestive heart failure and peptic ulcer disease. As part of the 
patient's therapy a low sodium diet (500 mg/day) was or-
dered, but hourly doses of an antacid containing large 
amounts of sodium also were prescribed. The computer sug-
gested that an antacid with a low sodium content be used in-
stead. The physician felt this was a good suggestion and 
changed the antacid prescription. 
Both of these cases could have been detected by a phar-
macist monitoring therapy with the patient's chart. The 
medication monitoring system, however, allowed the phar-
macist to detect these problems in the normal course of 
filling the prescription order. Additional pharmacist time 
was not required to detect these problems. Indeed, 30 sec-
onds is the average time needed to enter a drug order into 
the computer, have it type a label and process the data for 
possible contraindications. 
Conclusion 
The medication monitoring system makes the pharmacist 
more efficient and accurate in monitoring patient drug 
therapy. By monitoring each patient automatically, the 
system helps tedious, sometimes difficult, monitoring, while 
enabling the pharmacist to monitor more patients. It warns 
the pharmacist of potential problems much more quickly 
than do manual monitoring techniques. Oversight errors also 
are reduced. 
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Computerized monitoring systems that can detect only 
drug-drug interactions overlook many important problems. 
Table 1 shows that drug-drug interactions accounted for only 
28.9% of our alerts. A significant need to use laboratory data 
in monitoring patient drug therapy has been shown. Of all 
alerts, 44.9% involved laboratory data. 
Our findings have resulted in a hospitalwide expansion 
of the medication monitoring system. The cost of the com-
puter system is $0.35 per patient day and is included in the 
pharmacy charge for medication. Future efforts will be 
aimed at the expansion of HELP sector logic to make a more 
complete drug monitoring system. Cost justification studies 
and studies to determine the effect of the medication mon-
itoring system on patient care are underway. 
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The primary objective of this column is to present basic in-
formation and principles of electronic data processing (EDP) . 
The second objective of the column is to provide the hospi-
tal pharmacist involved with data process ing with the mecha· 
nism to interchange information. Readers are urged to submit 
contributions on their work with EDP. 
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